These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22442117)

  • 41. New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection.
    Bellusci L; Laurino A; Sabatini M; Sestito S; Lenzi P; Raimondi L; Rapposelli S; Biagioni F; Fornai F; Salvetti A; Rossi L; Zucchi R; Chiellini G
    Front Pharmacol; 2017; 8():905. PubMed ID: 29311919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tissue distribution and excretion of 125I-lidamycin in mice and rats.
    Liu YP; Li QS; Huang YR; Liu CX
    World J Gastroenterol; 2005 Jun; 11(21):3281-4. PubMed ID: 15929183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone.
    Scanlan TS; Suchland KL; Hart ME; Chiellini G; Huang Y; Kruzich PJ; Frascarelli S; Crossley DA; Bunzow JR; Ronca-Testoni S; Lin ET; Hatton D; Zucchi R; Grandy DK
    Nat Med; 2004 Jun; 10(6):638-42. PubMed ID: 15146179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular Evolution and Functional Divergence of Trace Amine-Associated Receptors.
    Eyun SI; Moriyama H; Hoffmann FG; Moriyama EN
    PLoS One; 2016; 11(3):e0151023. PubMed ID: 26963722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vasoconstrictor Effects of Trace Amine-Associated Receptor Agonists in the Isolated Perfused Rat Kidney.
    Jragh D; Yousif MHM; Oriowo MA
    Med Princ Pract; 2024; 33(6):537-544. PubMed ID: 39047696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thyronamines and Derivatives: Physiological Relevance, Pharmacological Actions, and Future Research Directions.
    Hoefig CS; Zucchi R; Köhrle J
    Thyroid; 2016 Dec; 26(12):1656-1673. PubMed ID: 27650974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies.
    Tonelli M; Espinoza S; Gainetdinov RR; Cichero E
    Eur J Med Chem; 2017 Feb; 127():781-792. PubMed ID: 27823885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of scopolamine pretreatment on 3-iodothyronamine (T1AM) effects on memory and pain in mice.
    Laurino A; Lucenteforte E; De Siena G; Raimondi L
    Horm Behav; 2017 Aug; 94():93-96. PubMed ID: 28711308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of trace amine-associated receptors in the Grueneberg ganglion.
    Fleischer J; Schwarzenbacher K; Breer H
    Chem Senses; 2007 Jul; 32(6):623-31. PubMed ID: 17556730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biosynthesis of 3-Iodothyronamine From T4 in Murine Intestinal Tissue.
    Hoefig CS; Wuensch T; Rijntjes E; Lehmphul I; Daniel H; Schweizer U; Mittag J; Köhrle J
    Endocrinology; 2015 Nov; 156(11):4356-64. PubMed ID: 26348473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression.
    Assadi-Porter FM; Reiland H; Sabatini M; Lorenzini L; Carnicelli V; Rogowski M; Selen Alpergin ES; Tonelli M; Ghelardoni S; Saba A; Zucchi R; Chiellini G
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29786646
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hit-to-Lead Optimization of Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists with a Diphenylmethane-Scaffold: Design, Synthesis, and Biological Study.
    Chiellini G; Nesi G; Sestito S; Chiarugi S; Runfola M; Espinoza S; Sabatini M; Bellusci L; Laurino A; Cichero E; Gainetdinov RR; Fossa P; Raimondi L; Zucchi R; Rapposelli S
    J Med Chem; 2016 Nov; 59(21):9825-9836. PubMed ID: 27731647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of neuronal trace amine-associated receptor (Taar) mRNAs in leukocytes.
    Nelson DA; Tolbert MD; Singh SJ; Bost KL
    J Neuroimmunol; 2007 Dec; 192(1-2):21-30. PubMed ID: 17900709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Multitarget Ligand 3-Iodothyronamine Modulates β-Adrenergic Receptor 2 Signaling.
    Dinter J; Khajavi N; Mühlhaus J; Wienchol CL; Cöster M; Hermsdorf T; Stäubert C; Köhrle J; Schöneberg T; Kleinau G; Mergler S; Biebermann H
    Eur Thyroid J; 2015 Sep; 4(Suppl 1):21-9. PubMed ID: 26601070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of Trace Amine-Associated Receptors in the Murine and Human Hippocampus Based on Public Transcriptomic Data.
    Katolikova NV; Vaganova AN; Efimova EV; Gainetdinov RR
    Cells; 2022 Jun; 11(11):. PubMed ID: 35681508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 3-Iodothyronamine-mediated metabolic suppression increases the phosphorylation of AMPK and induces fuel choice toward lipid mobilization.
    Ju H; Shin H; Son C; Park K; Choi I
    Horm Metab Res; 2015 Jul; 47(8):605-10. PubMed ID: 25372779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases.
    Laurino A; Landucci E; Raimondi L
    Front Endocrinol (Lausanne); 2018; 9():290. PubMed ID: 29928258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation.
    Braulke LJ; Klingenspor M; DeBarber A; Tobias SC; Grandy DK; Scanlan TS; Heldmaier G
    J Comp Physiol B; 2008 Feb; 178(2):167-77. PubMed ID: 17912534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The 3-iodothyronamine (T1AM) and the 3-iodothyroacetic acid (TA1) indicate a novel connection with the histamine system for neuroprotection.
    Laurino A; Gencarelli M; Raimondi L
    Eur J Pharmacol; 2021 Dec; 912():174606. PubMed ID: 34717926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GPR39 splice variants versus antisense gene LYPD1: expression and regulation in gastrointestinal tract, endocrine pancreas, liver, and white adipose tissue.
    Egerod KL; Holst B; Petersen PS; Hansen JB; Mulder J; Hökfelt T; Schwartz TW
    Mol Endocrinol; 2007 Jul; 21(7):1685-98. PubMed ID: 17488974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.